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EgressHerpesviruses must cross the inner nuclear membrane and underlying lamina to exit the nucleus. HSV-1 US3
and PKC can phosphorylate lamins and induce their dispersion but do not elicit all of the phosphorylated
lamin species produced during infection. UL13 is a serine threonine protein kinase conserved among many
herpesviruses. HSV-1 UL13 phosphorylates US3 and thereby controls UL31 and UL34 nuclear rim localization,
indicating a role in nuclear egress. Here, we report that HSV-2 UL13 alone induced conformational changes in
lamins A and C and redistributed lamin B1 from the nuclear rim to intranuclear granular structures. HSV-2
UL13 directly phosphorylated lamins A, C, and B1 in vitro, and the lamin A1 tail domain. HSV-2 infection
recapitulated the lamin alterations seen upon expression of UL13 alone, and other alterations were also
observed, indicating that additional viral and/or cellular proteins cooperate with UL13 to alter lamins during
HSV-2 infection to allow nuclear egress.
© 2009 Elsevier Inc. All rights reserved.Introduction
The nuclear envelope, comprised of the inner and outer nuclear
membranes (INM and ONM, respectively), deﬁne the nuclear rim and
separate the nucleus from the cytoplasm. The nuclear lamina is
comprised primarily of nuclear lamins, which form a network that
underlies and supports the nucleoplasmic face of the INM (Likhacheva
and Bogachev, 2001;Gruenbaum et al., 2005). Lamins A and C are A-
type lamins and alternative splice products of the same gene (Lin and
Worman, 1993). B-type lamins, subdivided into lamins B1 and B2, are
products of individual genes (Likhacheva and Bogachev, 2001).
Nuclear lamins have three domains: 1) a central alpha-helical rod
domain, 2) a globular head domain at the amino-terminus, and 3) a
globular tail domain at the carboxy-terminus. The nuclear lamina is a
dynamic structure that is disassembled during cell division. Reversible
phosphorylation at conserved serines within lamin head and tail
domains regulates the integrity of the nuclear lamina. Cdc2, PKC, and
MAP kinases phosphorylate lamins (Peter et al., 1992;Fields and
Thompson, 1995), and phosphorylation by Cdc2 of serine residues in
the head and tail domains results in lamin depolymerization during
mitosis (Heald and McKeon, 1990).
Herpesviruses are large, double-stranded DNA viruses that
replicate and assemble progeny virions in the nuclei of infected
cells, and hence must exit the nucleus to escape the cell. Because of
their large size, progeny virions cannot exit through nuclear pores andcal College, Harlingen, TX, USA.
ll rights reserved.therefore must cross the nuclear lamina to bud through the INM.
Complete dismantling of the nuclear envelope does not occur during
herpesvirus infection; however, infection appears to induce partial
lamin disassembly or reorganization to allow virions to reach the INM
(Scott and O'Hare, 2001;Mettenleiter, 2002;Reynolds et al., 2004).
The alphaherpesvirus, herpes simplex virus 1 (HSV-1), the
betaherpesviruses, murine cytomegalovirus (MCMV) and human
cytomegalovirus (HCMV), and the gammaherpesvirus Epstein–Barr
virus (EBV) all induce nuclear lamin alterations (Scott and O'Hare,
2001;Reynolds et al., 2004;Muranyi et al., 2002;Marschall et al., 2005;
Simpson-Holley et al., 2004;Lee et al., 2008). The MCMV proteins
M50/p35 and M53/p38, and the HCMV proteins pUL50 and pUL53,
form complexes that localize and recruit PKC to the nuclear rim
(Muranyi et al., 2002;Milbradt et al., 2007). This recruitment leads to
phosphorylation of lamins A, C, and B (Muranyi et al., 2002). TheM50/
p53 and M50/p38 homologues HSV-1 UL31 and UL34, respectively,
also form complexes that localize to the nuclear rim (Reynolds et al.,
2001). HSV-1 infection does not result in gross loss of lamins A and C.
Rather, HSV-1 infection is thought to induce conformational changes
within the head and tail domains of lamins A and C, leading to
masking of the epitopes recognized by selected lamin A/C antibodies
(Reynolds et al., 2004). HSV-1 UL31 and UL34 are necessary but not
sufﬁcient to cause the alterations to lamins A and C that occur during
HSV-1 infection, indicating a role for additional viral protein(s) in this
process (Reynolds et al., 2004). PKC recruitment to the nuclear rim
during HSV-1 infection requires UL31 and UL34, and PKC also
mediates phosphorylation of lamin B during infection (Park and
Baines, 2006). However, lamin B phosphorylation is only partially
reduced by PKC inhibitors and direct phosphorylation of lamin B by
PKC has not been shown (Park and Baines, 2006). These observations
138 G.L. Cano-Monreal et al. / Virology 392 (2009) 137–147indicate that additional viral protein kinases participate in lamin B
phosphorylation during HSV infection.
HSV-1 and HSV-2 encode two serine/threonine protein kinases,
US3 and UL13, which may phosphorylate lamins during nuclear
egress. US3 is packaged into the virion and is conserved only among
the alpha herpesviruses (Purves et al., 1987;Smith and Smith, 1989).
Proper localization of UL34, UL31, and PKC at the nuclear rim during
HSV-1 egress requires US3 (Kato et al., 2006), and phosphorylation of
UL31 by US3 controls capsid egress from the nucleus (Mou et al.,
2009). HSV-1 US3 also can phosphorylate lamins A and C in vitro at
multiple sites (Mou et al., 2007). However, phosphorylation by US3
does not account for all of the phosphospecies of lamins A and C seen
in HSV-1 infected cells (Mou et al., 2007). UL13 and its homologs are
components of the viral tegument, are synthesized as late gene
products, and are conserved among alpha, beta and gamma
herpesviruses (Overton et al., 1992;Kawaguchi and Kato, 2003). This
extensive conservation suggests an important role for UL13 in the
herpesvirus replication cycle. The HCMV UL13 homolog UL97 may
play a role in nuclear egress because it can directly phosphorylate
lamins A, C, and B in vitro and induces lamin alterations in transfected
and infected cells (Marschall et al., 2005). UL13 may be involved in
tegument dissociation (Morrison et al., 1998), viral gene expression
(Purves and Roizman, 1992;Purves et al., 1993;Tanaka et al., 2005),
and cell cycle regulation (Advani et al., 2000). HSV-1 UL13 can
phosphorylate US3, and proper localization of UL31 and UL34 also
depends on UL13 (Kato et al., 2006), indicating an additional role for
UL13 in HSV nuclear egress.
We previously noted alterations in nuclear morphology in cells
transfected with UL13, but not with an enzymatically-inactive UL13
(K176A) (Geiss et al., 2004). These alterations were not due to
apoptosis. Therefore, we tested the possibility that UL13 kinase
activity alters the integrity of the nuclear lamina by targeting the
nuclear lamins.
Results
HSV-2 UL13 induces conformational changes in lamins A and C
To investigate the effects of UL13 kinase activity on lamins A and C,
cells were transfected with plasmids expressing UL13-HA or the
enzymatically-inactive UL13-K176A-HA, and lamins A and C were
detected using a monoclonal antibody previously found to recognize
epitopes in the lamin tail domain (Reynolds et al., 2004) (Fig. 1). In
UL13-K176A-HA-expressing cells, UL13-K176A-HA was both nuclear
and cytoplasmic (Fig. 1A) and lamins A and C were tightly conﬁned to
the nuclear rim (Fig. 1B), resembling the staining seen in untrans-
fected cells. The majority of UL13-K176A-HA did not colocalize with
lamins A and C (Fig. 1C). In contrast, in UL13-HA-expressing cells,
UL13-HA was found almost exclusively in the nucleus (Fig. 1D) and
staining with the lamin A/C monoclonal antibody was decreased at or
absent from the nuclear rim (Fig. 1E). In many UL13-HA-expressing
cells displaying undetectable lamin staining at the nuclear rim, some
lamins remained in the nuclear interior (Fig. 1G). To quantify the
change in lamin staining intensity, the intensity in UL13-HA and UL13-
K176A-HA-expressing cells was analyzed inmultiple ﬁelds and ranked
as high, medium, or undetectable (Fig. 1H). The results revealed a
statistically signiﬁcant difference in lamin staining between UL13-HA-
and UL13-K176A-HA-expressing cells at all intensity levels (Fig. 1I),Fig. 1. The intensity of lamin A and C staining with a monoclonal antibody differs in HeLa cells
HA (A–C) or UL13-HA (D–F) expression constructs. At 18 h post-transfection, cells were ﬁxed
examined by confocal microscopy. Images showing both transfected and untransfected cells
representative images are shown. (G) Confocal images showing cells with lamins remain
monoclonal lamin A/C antibody (red), and DAPI (blue). (H) Ten random ﬁelds were analyzed
(ND) by a masked observer. Examples are denoted by arrowheads. (I) Graph shows the mewith the greatest difference occurring in undetectable staining. The
images shown are cells 18 h post-transfection; however, the same
phenotype was observed at all two-hour increments from 12 to 24 h
post-transfection (data not shown). Therefore, the enzymatic activity
of UL13 induces changes in nuclear lamins A and/or C such that a
decrease in lamin staining intensity is observed at the nuclear rim
with a lamin A/C monoclonal antibody recognizing an epitope in the
tail domain.
Differential detection of lamins A/C in HSV-1-infected cells led to
the conclusion that HSV-1 infection causes conformational changes to
lamins A and C that mask the epitope for the lamin A/C monoclonal
antibody in the tail domain (Reynolds et al., 2004). To investigate the
possibility that the reduction in lamin staining induced by HSV-2 UL13
was also due to altered lamin conformation rather than loss of lamins
A/C, we utilized a polyclonal lamin A/C antibody recognizing epitopes
in the rod domain of lamins A and C to observe the staining intensity
of lamins A and C in UL13-HA- and UL13-K176A-HA-transfected cells.
In mock transfected cells, the polyclonal lamin A/C antibody detected
more intranuclear lamins (Figs. 2B and E) than had the lamin A/C
monoclonal antibody (Figs. 1B and E), as previously observed
(Reynolds et al., 2004). Importantly, there was no statistically
signiﬁcant difference in lamin staining intensity between UL13-HA
and UL13-K176A-HA-expressing cells (Fig. 2G). UL13-HA colocalized
with intranuclear lamins, whereas UL13-K176A-HA did not (Figs. 2C
and F). However, staining with the polyclonal antibody against the rod
domain revealed that both UL13-HA and UL13-K176A-HA colocalized
more frequently with the lamins at the nuclear rim (Figs. 2C and F).
These results indicate that no large-scale loss of lamins A and C
occurred in UL13-HA-transfected cells.
HSV-2 UL13 induces lamin B1 alterations
To determine the effects of HSV-2 UL13 expression on lamin B1,
HeLa cells were transfected with plasmids expressing UL13-HA or
enzymatically-inactive UL13-K176A-HA, and lamin B1 was detected
using a polyclonal antibody. The distribution of UL13-K176-HA and
UL13-HA after transfection was consistent with earlier observa-
tions: UL13-K176A-HA localized to the nucleus and cytoplasm and
UL13-HA to the nucleus (Figs. 3A and D). In UL13-K176A-HA-
expressing cells, lamin B1 staining was conﬁned to the nuclear rim
(Fig. 3B) and resembled that of untransfected cells. UL13-HA expres-
sion caused redistribution of lamin B1 from the nuclear rim to an
intranuclear punctuate pattern (Fig. 3E). This pattern was observed
from 12 through 24 h post-transfection (data not shown). UL13-
K176A-HA colocalized with lamin B1 at the nuclear rim (Fig. 3C)
and UL13-HA colocalized with lamin B1 at some of the intranuclear
puntae (Fig. 3F). The difference in redistribution of lamin B1 from
the nuclear rim to intranuclear puncta in UL13-HA-compared with
UL13-K176A-HA-expressing cells was statistically signiﬁcant (Fig.
3G). Therefore, enzymatically active UL13 can induce lamin B1
redistribution.
HSV-2 UL13 can directly phosphorylate lamins A, C, and B1
Phosphorylation is one mechanism by which HSV-2 UL13 could
alter conformation or distribution of lamins A, C and B1. Thus, a
mixed-bed in vitro kinase assay was performed to determine the
capacity of UL13 to directly phosphorylate lamins A, C, and B1. Theexpressing UL13-HA or UL13-K176A-HA. HeLa cells were transfected with UL13-K176A-
, stained with anti-HA antibody (green) and monoclonal lamin A/C antibody (red), and
were merged (C and F). All images were obtained at the same microscope settings and
ing in the nuclear interior. Cells were ﬁxed, stained with anti-HA antibody (green),
and lamin staining in each cell was ranked as high ormedium intensity or not detectable
an ± SD from three experiments.
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Fig. 2. Lamin A and C staining with a polyclonal antibody does not differ in HeLa cells expressing UL13-HA or UL13-K176A-HA. HeLa cells were transfectedwith UL13-K176A-HA (A–C)
or UL13-HA (D–F) expression constructs. At 18 h post-transfection, cells were ﬁxed, stained with anti-HA antibody (green) and a polyclonal lamin A/C antibody (red), and examined
by confocal microscopy. Images showing both transfected and untransfected cells were merged (C and F). All images were obtained at the same microscope settings and
representative images are shown. Ten random ﬁelds were analyzed and lamin staining in each cell was ranked as high or medium intensity or not detectable (ND) by a masked
observer. (G) Graph shows the mean ± SD from three experiments. No signiﬁcant differences between UL13-K176A-HA and UL13-HA were observed (P = 0.2482 to 0.4685).
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expressed by in vitro translation and then incubated with anti-HA
antibody. The substrates, endogenous lamins A, C, and B1 from HeLa
cell lysates, were incubated with their respective anti-lamin anti-
bodies. As a negative control substrate for the phosphorylation assay,
HSV-2 VP16 was transfected into HeLa cells and the lysates were
incubated with anti-VP16 antibody. The enzymes and substrates
bound to their respective antibodies were coimmunoprecipitated
using protein A/G agarose beads, then utilized in an in vitro kinase
assay containing [γ32P] ATP. Following the in vitro kinase assay, theproducts were separated by SDS-PAGE and probed by western blot for
HA-tagged UL13 or UL13-K176A, lamins A, C, and B1, and VP16 (Figs.
4A–D, respectively). 32P-labeled products were observed by auto-
radiography of the western blots (Figs. 4E–H). As expected, UL13-HA
and UL13-K176A-HA were expressed (Fig. 4A) but only UL13-HA
autophosphorylated (Cano-Monreal et al., 2008) (Figs. 4E–H). Lamins
A, C, and B1were phosphorylated by UL13-HA but not by UL13-K176A-
HA (Figs. 4F and G, respectively). Phosphorylation of lamins by UL13-
HA was speciﬁc because VP16 was not phosphorylated (Figs. 4D and
H). Thus, HSV-2 UL13 can phosphorylate lamins A, C, and B1 in vitro.
Fig. 3. The pattern of lamin B1 staining differs in HeLa cells expressing UL13-HA or UL13-K176A-HA. HeLa cells were transfected with UL13-K176A-HA (A–C) or UL13-HA (D–F)
expression constructs. At 18 h post-transfection, cells were ﬁxed, stained with anti-HA antibody (green) and a polyclonal lamin B1 antibody (red), and examined by confocal
microscopy. Images showing both transfected and untransfected cells were merged (C and F). All images were obtained at the same microscope settings and representative images
are shown. Ten random ﬁelds were analyzed for punctate, intranuclear lamin staining by a masked observer. (G) Graph shows the mean ± SD from three experiments.
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Lamins must be phosphorylated at conserved serines in their head
and tail domains during cell division for disassembly to occur. The loss
of monoclonal antibody binding to the lamin A tail domain that
occurred in the presence of UL13 would be consistent with a
phosphorylation-induced conformational change leading to disas-
sembly. We therefore determined whether HSV-2 UL13 can phos-phorylate the lamin tail domain. Full-length lamin A and the tail
domain were cloned and used as substrates in an in vitro kinase assay
with HSV-2 UL13. UL13-HA and UL13-K176A-HA, and full-length
lamin A or the tail domain were expressed by in vitro transcription/
translation reactions and then incubated with HA-speciﬁc or lamin-
speciﬁc antibodies, respectively. These enzyme-antibody and sub-
strate–antibody combinations were mixed and coimmunoprecipi-
tated, and then subjected to an in vitro kinase assay. UL13-HA and
Fig. 4. HSV-2 UL13-HA can phosphorylate lamins A, C, and B1 in vitro. In vitro translated UL13-HA and UL13-K176A-HA, lamins A, C or B1 extracted from HeLa cells, and VP16 from
transfected HeLa cells were isolated bymixed-bed immunoprecipitation. The immunoprecipitates were subjected to an in vitro kinase assay, the products were resolved by SDS-PAGE
and detected by western blot using (A) anti-HA antibody, (B) lamin A/Cmonoclonal antibody, (C) lamin B1 polyclonal antibody, or (D) VP16monoclonal antibody. (E–H) 32P-labeled
proteins were detected by autoradiography of the western blots. The UL13-HA and UL13-K176A-HA western blot shown in panel A is representative of the entire experiment. The
arrowheads denote UL13-HA autophosphorylation. Bullets beside western blots denote non-speciﬁc bands. Lamin A, B and C bands are denoted by their respective letters.
142 G.L. Cano-Monreal et al. / Virology 392 (2009) 137–147UL13-K176A-HA were detected by western blot in immunoprecipita-
tions alone or in coimmunoprecipitations with full-length lamin A
(Fig. 5A). Full-length lamin A was readily detectable following
translation in the reticulocyte lysate and after immunoprecipitation
by western blot with anti-lamin antibody (Fig. 5B). AutoradiographyFig. 5.HSV-2 UL13-HA can directly phosphorylate the tail domain of lamin A. In vitro transcrib
Awere isolated by mixed-bed immunoprecipitation and the immunoprecipitates were subje
length lamin and 12% gel for the tail domain), and detected by western blot and autoradiogr
lamin A detected by western blot with anti-lamin antibody, and (C) 32P-labeled proteins det
(E) 35S-labeled and 32P-labeled proteins and (F) 32P-labeled proteins detected by autoradiogr
mobility as light chain and other cross reacting bands.revealed autophosphorylated UL13-HA, and a 32P-labeled band
corresponding to the mobility of full-length lamin A in coimmuno-
precipitates with UL13-HA but not UL13-K176A-HA (Fig. 5C). In a
second kinase assay, 35S-labeled lamin A tail domain was coimmuno-
precipitated with UL13-HA or UL13-K176A-HA. The western bloted and translated UL13-HA and UL13-K176A-HA, and full-length or tail domain of lamin
cted to an in vitro kinase assay. The products were resolved by SDS-PAGE (8% gel for full-
aphy. (A) UL13-HA and UL13-K176A-HA detected with anti-HA antibody, (B) full-length
ected by autoradiography; (D) UL13-HA and UL13-K176A-HA detected by western blot,
aphy. The lamin tail domainwas not discernible by western blot because it has the same
143G.L. Cano-Monreal et al. / Virology 392 (2009) 137–147probed with anti-HA antibody showed UL13-HA and UL13-K176A-HA
were present as expected (Fig. 5D). The ﬁrst layer of ﬁlm revealed a
radiolabeled band of mobility corresponding to the 35S-labeled lamin
A tail which was immunoprecipitated from the reticulocyte lysate and
coimmunoprecipitated with UL13-HA and UL13-K176A-HA (Fig. 5E).
The second layer of ﬁlm revealed 32P-labeled bands corresponding to
lamin A tail in the presence of UL13-HA but not UL13-K176A-HA, as
well as autophosphorylated UL13-HA (Fig. 5F). Thus, UL13 can
phosphorylate in vitro full-length lamin A and one or more sites in
the tail domain.
HSV-2 infection changes the nuclear lamina
We next asked whether the alterations to lamins A, C and B1
observed in transfected cells expressing UL13-HA occur during
infection with HSV-2. Because antibodies to HSV-2 UL13 have been
difﬁcult to raise, we constructed HSV-2 recombinants of the parental
strain 333 encoding an HA-tagged UL13 (HSV-2 333-UL13-HA). Two
independent isolates replicated nearly as well as wild-type 333 in
Vero and HeLa cells after infection at low moi (Fig. 6), though the
minor differences at each time point were statistically signiﬁcant. We
used HSV-2 333-UL13-HA to observe UL13-HA and the distribution of
lamins A, C, and B1 in the context of HSV-2 infection. HeLa cells were
left uninfected (Figs. 7A, E, I) or were infected with 333-UL13-HA at
MOI of 5 for 18 h . Cells were stained with anti-HA and anti-lamin
monoclonal and polyclonal antibodies used in the transfection studies
to determine whether differential staining with the two also occurs
during infection, and were observed by confocal microscopy. As in the
UL13-HA transfection experiments, UL13 staining was predominantlyFig. 6.HSV-2 333-UL13-HA replicates similarly to wild-type HSV-2 333. (A) Vero cells or
(B) HeLa cells were infected in duplicate at MOI 0.01 with HSV-2 333 or with
independent isolates of HSV-2 333-UL13-HA. Cultures were harvested at the indicated
times and virus titers were determined by plaque assay. Data points are the geometric
mean±SEM of duplicate wells from three independent experiments. ⁎P= 0.0274;
⁎⁎P= 0.0066 to 0.0098; ⁎⁎⁎P b0.0001 to 0.0007 for 333 comparedwith 333-UL13-HA 1.nuclear during infection (Figs. 7B, F, J). Also as seen in UL13-HA-
transfected cells, some infected cells showed a decrease in lamin
staining intensity with the monoclonal lamin A/C antibody (Fig. 7C,
arrowhead). Decreased lamin A/C staining occurred in more cells
infected with HSV-2 333-UL13-HA, and high levels of lamin staining
were observed more often in mock-infected cells (Fig. 7M). Additional
abnormalities in lamins A/C were observed in infected cells, including
discontinuous nuclear rim staining (Fig. 7C, asterisk), and increased
intranuclear lamin staining (Fig. 7C, open block arrows). Staining
intensity with the polyclonal lamin A/C antibody did not decrease,
resemblingwhat had been observed in UL13-HA and UL13-K176A-HA-
transfected cells. There were, however, abnormalities in the lamin
staining pattern observed with the polyclonal lamin A/C antibody,
including invagination (Fig. 7G, arrow) and discontinuous staining at
the nuclear rim (Fig. 7G, asterisk). Staining for lamin B1 in infected
cells did not reveal the redistribution seen in UL13-HA-transfected
cells. Instead, decreased lamin B1 staining was observed (Fig. 6K,
arrowhead), as well as invagination (Fig. 7K, arrows), and discontin-
uous nuclear rim staining (Fig. 7K, asterisks). These lamin alterations
were observed in cells stained 12 through 24 h post-transfection and
in HeLa cells infected with wild-type HSV-2 (data not shown). As was
seen in transfected cells, the majority of UL13-HA in infected cells did
not appear to colocalize with lamins which had been stained with the
monoclonal lamin A/C or polyclonal lamin B1 antibodies. However, a
high degree of colocalizationwas observed when the polyclonal lamin
A/C antibody was used. Altogether, the variety of phenotypes seen in
infected cells was greater than that seen in UL13-HA-transfected cells.
Therefore, UL13 is sufﬁcient to cause some but not all of the lamin
alterations observed in infected cells.
Discussion
Herpesviruses replicate in the host cell nucleus and must disrupt
the nuclear lamina to continue the process of virion assembly and
egress from the cell. We have found that the HSV-2 UL13 protein
kinase alters the nuclear lamins. Extensive colocalization is observed
between nuclear lamins and UL13-HA or UL13-K176A-HA, especially
at the nuclear rim. HSV-2 UL13-HA but not the enzymatically-inactive
UL13-K176A-HA induces changes in lamins A and C that result in loss
ofmonoclonal but not polyclonal antibody binding, presumably due to
masking of the monoclonal antibody epitope in the tail domain. UL13-
HA but not UL13-K176A-HA also causes redistribution of lamin B1 to
the nuclear interior. HSV-2 UL13 can directly phosphorylate lamins A,
C, and B1 in an in vitro kinase assay, suggesting that lamin alterations
induced by HSV-2 UL13 in cells could result from direct phosphoryla-
tion by UL13. Examination of lamins in HSV-2 infected cells revealed
multiple alterations, not all of which were seen in cells expressing
UL13 alone, indicating that multiple viral proteins play a role in
altering lamins during infection.
Differential staining with antibodies to lamins A and C detected a
change in the lamin tail domain in the presence of UL13-HA.
Decreased staining of lamins A and C at the nuclear rim of UL13-HA-
expressing cells compared with untransfected cells was observed
when a monoclonal lamin A/C antibody that recognizes epitopes in
the lamin tail domain was used. Lamins A and C that had relocated to
the nuclear interior in UL13-HA-expressing cells were detected only at
low levels, and the remaining lamin staining did not substantially
colocalize with UL13-HA. This decrease in lamin A/C staining was not
observed, however, with a polyclonal lamin A/C antibody recognizing
epitopes in the lamin rod domain. Therefore UL13 appears to induce
conformational changes in the tail domain of lamins A and C, and only
residual lamins not associated with and modiﬁed by UL13 remain
detectable with the monoclonal antibody. Alternatively, decreased
staining of lamins A and C could represent preferential degradation of
a subset of lamins A and C when associated with UL13, a subset
recognized by the monoclonal antibody. Such loss of lamins A and C
Fig. 7. Infectionwith HSV-2 encoding HA-tagged UL13 alters the nuclear lamin network. HeLa cells were left uninfected (A, E, I) or were infected with HSV-2 333-UL13-HA at an MOI
of 5. At 18 h post-infection, cells were ﬁxed, stained with anti-HA antibody (green) and anti-lamin antibodies (red). Antibodies used were (A–D) monoclonal lamin A/C antibody,
(E–H) polyclonal lamin A/C antibody, or (I–L) polyclonal lamin B1 antibody. Cells were analyzed by confocal microscopy and the anti-HA and anti-lamin images were merged. All
images were obtained at the same microscope settings, and representative images are shown. Abnormalities in the lamin staining pattern include decreased lamin staining,
arrowhead; invagination, arrow; increased intranuclear lamin staining, open block arrow; and discontinuous staining at the nuclear rim, asterisk. (M) Fifteen random ﬁelds of
infected cells and three random ﬁelds of mock-infected cells were analyzed and lamin staining intensity was ranked as high, medium or low by a masked observer. Graph shows the
mean ± SD.
144 G.L. Cano-Monreal et al. / Virology 392 (2009) 137–147would not be detected if the subset recognized by the monoclonal
antibody was only a minor fraction of those lamins recognized by the
polyclonal antibody, whose staining intensity was maintained.
Lamins contain conserved serines in their head and tail domains
that must be phosphorylated for lamin disassembly to occur. Thisnormally occurs during cell division though the action of cellular
kinases. The Cdc2-kinase phosphorylates lamin A at sequences with
the motif S/TPxS/R that are functionally important in lamin
disassembly (Haas and Jost, 1993). We have previously shown that
the amino acid pair SP can be aminimal recognition sequence for HSV-
145G.L. Cano-Monreal et al. / Virology 392 (2009) 137–1472 UL13 phosphorylation (Cano-Monreal et al., 2008). Lamins A and C
contain one SP sequence in the head domain and three SP sequences
in the mature tail domain, but no SP sequences in the intervening rod
domain. Here, we have shown that HSV-2 UL13 can phosphorylate
lamins A and C in vitro. UL13 also can phosphorylate the tail domain of
lamin A in vitro, suggesting that the decreased reactivity seenwith the
monoclonal antibody recognizing epitopes in the tail domain of
lamins A and C could be due to a conformational change in this region
induced by HSV-2 UL13 phosphorylation. Alternatively, phosphoryla-
tion of the tail domain by UL13may permit the association of lamins A
and C with another cellular protein, leading to epitope masking.
The capacity of HSV-2 UL13 to phosphorylate the lamin A tail
domain implies that UL13 phosphorylates the lamin tail in infected
cells, leading to a conformational change that facilitates their
dissolution. Disruption of lamin A polymers by UL13 would likely
facilitate virion egress through the nuclear envelope (Mou et al.,
2008). Cdc2 causes disassembly of lamin A/C polymers by phosphor-
ylation of serine 22 in the head domain and 390 and 392 in the tail
domain (Heald and McKeon, 1990). The UL13 homolog in Epstein–
Barr virus, BGLF4 kinase, can phosphorylate lamin A head and tail
domains in vitro, and serine 22, serine 390 and serine 392 are
important in EBV-induced redistribution of nuclear lamin A (Lee et al.,
2008). The HCMV homolog of UL13, UL97, alsomimics Cdc2 activity by
phosphorylating serine 22 and serine 390 in vitro. In addition,
phosphorylation of serine 22 and serine 392 in HCMV-infected cells
and disruption of the nuclear lamina depends upon UL97 (Hamirally
et al., 2009). Although HSV-2 UL13 does not recognize substrates by
using the Cdc2 motif, its capacities to utilize SP as a minimal
recognition sequence (Cano-Monreal et al., 2008), to disrupt the
nuclear lamina, and to phosphorylate the SP-containing tail domain of
lamin A in vitro suggest that HSV-2 UL13 and its HCMV and EBV
counterparts mediate lamin disassembly through similar mechan-
isms. An investigation of the site(s) phosphorylated on lamin A by
HSV-2 UL13 is underway to address this question.
HSV-2 UL13-HA but not the enzymatically-inactive UL13-K176A-
HA redistributed lamin B1 from the nuclear rim to the intranuclear
space, but a decrease in lamin B1 staining was not observed (Fig. 3).
Lamin B associates with the lamin B receptor (LBR), an integral
membrane protein that anchors lamin B to the INM. Upon lamin
phosphorylation during mitosis, lamin B remains bound to the LBR
and remnants of the nuclear envelope (Gerace and Blobel, 1980). HSV-
1 infection of COS-1 cells results in redistribution of a LBR-GFP fusion
protein to the cytoplasm and lamin B1 to the cytoplasm and nuclei
(Scott and O'Hare, 2001). Lamin B relocalization to the cytoplasm also
occurs during HSV-1 infection of HEp-2 and HeLa cells (Park and
Baines, 2006). The HCMV UL13 homologue UL97 induces redistribu-
tion of LBR from the nuclear rim to intranuclear granular structures,
and this event is dependent on UL97 enzymatic activity. We did not
examine the effect of HSV-2 UL13-HA on LBR; howeverwe did observe
a similar relocalization of lamin B1 to the intranuclear space.
Therefore, the protein kinase activities of UL13 and UL97 may
redistribute lamin B and LBR to similar intranuclear structures.
Infection of cells with HSV-2 revealed additional alterations not
observed when UL13-HAwas expressed alone, although UL13-HAwas
found almost exclusively within the nucleus and nuclear rim in both
transfected and infected cells. Previous transfection and infection
studies have implicated the HSV-1 proteins UL31, UL34, and US3
(Reynolds et al., 2004;Mou et al., 2007) and the cellular PKCs (Park
and Baines, 2006) in altering lamins. However, none of these proteins
fully account for the lamin alterations seen during infection (Park and
Baines, 2006), indicating additional viral or cellular proteins are
necessary. During HSV-1 infection, UL13 phosphorylates US3 and
participates in determining the proper localization of UL31 and UL34
at the nuclear rim (Kato et al., 2006). We found that HSV-2 UL13,
when expressed alone, induces alterations in lamins A, C, and B1 and
can directly phosphorylate lamins A, C, and B1 in vitro. The inﬂuenceof HSV-1 UL13 on other proteins that regulate integrity of the nuclear
lamina raises the possibility that HSV-2 UL13 could phosphorylate
lamins as well as other viral protein(s) to cooperatively achieve
sufﬁcient lamin alteration and disassembly for virion egress through
the nuclear membrane to occur.
Finally, it is interesting to note that UL13-HA expressed by
transfection and UL13-HA in infected cells localizes almost exclusively
to the nucleus, but UL13-K176A-HA is distributed throughout the
cytoplasm as well as in the nucleus. Possibly HSV-2 UL13 becomes
trapped in the nucleus due to interaction with substrates or binding
partners. Protein kinase activity either plays a role in retention or the
mutant UL13-K176A protein does not adopt the proper conformation
for stable interaction with critical binding partner(s). Further work
will be needed to elucidate the mechanism underlying nuclear
retention of HSV-2 UL13.
Materials and methods
Cells and viruses
Vero cells were maintained in Dulbecco's modiﬁed Eagle medium
(DMEM) supplemented with 3% fetal calf serum, 3% newborn calf
serum, and 1% penicillin–streptomycin. HeLa cells were maintained in
DMEM supplemented with 10% bovine growth serum and 1%
penicillin–streptomycin. The wild-type HSV-2 strain 333, kindly
provided by Jim Smiley, was propagated in Vero cells. To create HSV-
2 333 UL13-HA virus, the HSV-2 UL13 ORF was ampliﬁed by PCR from
HSV-2 333 genomic DNA in two fragments. For the ﬁrst fragment,
forward primer 5′-TTCTAACCGCACACCGACGGTACC and reverse pri-
mer 5 ′ -AGCGTAGTCTGGGACGTCGTATGGGTACGACAGAG-
GATCCCTTCCGCCCTCGAGC were used to amplify a region containing
UL13 and 145 bp of upstream UL14 sequence and to insert an HA tag
(underlined) at the C-terminus of UL13. For the second fragment, the
forward primer 5 ′-TACCCATACGACGTCCCAGACTACGCTT-
GAGGTCCCTTCCGCCCTCGAGC and the reverse primer 5′-GGAATTCCG-
TACTTGGCTCGGCACTTAAC ampliﬁed a region which included the
remainder of theUL13ORFand 1106 bp of downstreamUL12 sequence.
The forward primer from theﬁrst reaction and reverse primer from the
second reaction were then used to amplify full-length UL13 with a 3′
HA tag and ﬂanking sequences. The product was cloned into pRsetB
(Invitrogen). To generate the 333-UL13-HAvirus, pRsetB-UL13-HAwas
co-transfected into Vero cells with full-length 333 DNA using the
Amaxa nucleofection system. DNA prepared from plaque isolates was
subjected to PCR using primers ﬂanking the HA tag, and the PCR
products were screened by restriction enzyme digestionwith AatII for
a site present within the HA tag. Positive plaque isolates from two
independent transfections underwent three rounds of plaque puriﬁca-
tion. The genotype of the 333-UL13-HA viruses was conﬁrmed by
Southern blot performed as previously described (Korom et al., 2008).
Plasmids and transfections
UL13 constructs were derived from pSG5-UL13 (Geiss et al., 2004),
which contains the HSV-2 UL13 gene downstream of the SV40 early
promoter in pSG5 (Stratagene). pSG5-UL13-K176A contains an alanine
mutation at lysine 176, resulting in an enzymatically-inactive UL13.
The UL13 plasmids contain an HA tag fused to the carboxy-terminus of
UL13. pcDNA-333VP16 (Korom et al., 2008) contains HSV-2 VP16
downstream of a CMV promoter in pcDNA3.1 (Stratagene). Transfec-
tions were performed using Lipofectamine Plus (Invitrogen) accord-
ing to the manufacturer's recommendations.
Infections
For immunoﬂuorescence studies, HeLa cells were infected with
HSV-2 333 or 333-UL13-HA at MOI of 5. For growth curves, Vero and
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Cells were harvested at various time points and virus titers were
determined by plaque assay. Statistical signiﬁcance of difference in
titers at individual time points was determined by t-test.
Antibodies
Mouse anti-human lamin A/C monoclonal antibody 636 and goat
anti-human lamin B1 polyclonal antibody C-20 were obtained from
Santa Cruz Biotechnology. Rabbit anti-human lamin A/C polyclonal
antibody 2032 was obtained from Cell Signaling Technologies.
Mouse anti-VP16 monoclonal antibody 1-21 was obtained from
Santa Cruz Biotechnology. The rat anti-HA antibody 3F10 was
obtained from Roche Diagnostics. All antibodies were used accord-
ing to the manufacturer's recommendations. Secondary antibodies
conjugated with Alexa Fluors were obtained from Molecular Probes,
and FITC-conjugated anti-rat antibody was obtained from Jackson
Immunoresearch.
Indirect immunoﬂuorescence and confocal microscopy
HeLa cells were seeded onto glass coverslips in 12-well plates and
transfected with 2 μg of plasmid DNA, or were infected at a
multiplicity of infection (MOI) of 5. At 2 h intervals from 12 to
24 h post-infection or post-transfection cells were washed three
timeswith PBS and ﬁxedwith ice-coldmethanol at−20 °C for 20min.
Cells were washed with PBS and incubated for 1 h at room
temperature in PBS containing 1% BSA. Cells were then probed with
primary and secondary antibodies, washed with PBS, and mounted
onto glass slides using SlowFade containing DAPI (Molecular Probes).
Fluorescence was visualized using a 60× oil objective on a BioRad
1024 confocal scanningmicroscope. Images were capturedwith Image
J and formatted using Adobe Illustrator.
Quantitation of immunoﬂuorescence images
Ten random ﬁelds of cells were examined in masked fashion for
differences in lamin staining intensity (high, medium, or undetect-
able): high intensity was sharp and intense staining; medium
intensity was intermediate staining; and not detectable was nearly
complete absence of lamin staining. At least 100 cells were counted
per sample in each experiment by a blinded observer, and each
experiment was carried out in triplicate. The percentage of cells in
each category was determined by dividing the number of cells
staining high, medium, or undetectable by the total number of cells
counted. The percentages from three independent experiments were
used to ascertain the mean and standard deviation. An unpaired t-test
was used to determine statistical signiﬁcance of differences.
Mixed-bed immunoprecipitation
UL13-HA and UL13-K176A-HA were synthesized in vitro using the
TNT® T7 coupled transcription/translation reticulocyte lysate system
(Promega) according to the manufacturer's recommendations. The
translation products were pre-cleared twice for 30 min each with
protein A/G agarose beads (Oncogene Research) at 4°C in immuno-
precipitation (IP) buffer (50 mM Tris–HCl [pH 8.0], 150 mM NaCl, 1%
NP-40) supplemented with 40 mM sodium ﬂuoride, 1 mM sodium
orthovanadate, 10 mM β-glycerophosphate, 2 μg/ml aprotinin, 3 μg/
ml leupeptin, and 1 mM phenylmethylsulfonyl ﬂuoride, then were
bound by incubation with 3F-10 for 2 h . Lamins A, C, and B1 were
derived from HeLa cells and HSV-2 VP16 was derived from VP16-
transfected HeLa cells. To isolate these proteins, HeLa cells were
scraped into the medium and centrifuged at 1200 ×g for 15 min at
4 °C. The supernatant was removed and the pellet was resuspended in
IP buffer supplemented with complete EDTA-free protease inhibitorcocktail (Roche). Cells were lysed on ice for 20 min with periodic
mechanical disruption through a 25-ga needle. The lysate was
centrifuged at 12,000 ×g for 15 min at 4 °C and the supernatant
was retained for IP. Supernatants were pre-cleared twice for 30 min
each with protein A/G agarose beads at 4 °C in IP buffer and thenwere
incubated with anti-VP16, anti-lamin A/C or anti-lamin B1 antibodies
for 2 h. Enzyme-antibody and VP16-antibody or lamin-antibody
mixtures were combined and incubated with protein A/G agarose
beads for 2 h at 4 °C. The beads were washed three times with cold IP
buffer, and used in an in vitro kinase assay.
Full-length lamin A with the farnesylation site was cloned by
PCR ampliﬁcation of cDNA for human lamin A/C obtained from
Open Biosystems and insertion into pCDNA3.1 using primers
forward 5′-CACGAATTCCTGCCGGCCATCGAGACCCCG-3′ and reverse
3′-CTGGTCACCCGCTCCTACTAACTCGAGCACGACCAGTGGGCGAGGAT-
GATTGAGCTCGTGGTGCTCGAGTTAGTAGGAGCGGGTGACCAG-5′. The
lamin A tail domain was ampliﬁed using the same reverse primer
and forward primer 5′-CACGAATTCGCCGCCATGGAGAGGCTACGC-3′.
Full-length and tail domains of lamin A were expressed using the
TNT® T7 coupled transcription/translation system in the absence or
presence, respectively, of 35S-methionine and incubated with anti-
lamin antibody 636. These were individually mixed with UL13-
antibody complexes and mixed-bed immunoprecipitations were
performed as described above.
Mixed-bed in vitro kinase assay
Kinase assays were performed with UL13 and lamins or VP16
immobilized on protein A/G beads in a total volume of 25 μl kinase
assay buffer (25 mM Tris–HCl [pH7.5], 20 μM EGTA) supplemented
with Magnesium/ATP cocktail (Upstate) and 10 μCi [γ-32P]ATP
(Perkin Elmer; 3000 Ci/mmol) at 30 °C for 30 min. The reaction was
then centrifuged to separate supernatant from proteins bound to the
beads.
Western blot analysis
Proteins were resolved by SDS-PAGE and transferred to poly-
vinylidene diﬂuoride membranes (PVDF; Millipore). Target proteins
were probed with the appropriate antibody and detected with an
alkaline phosphatase-conjugated secondary antibody and BCIP/NBT
(Promega). To detect in vitro phosphorylated proteins, the blots were
dried and subjected to autoradiography and phosphorimager analysis.
Two layers of ﬁlmwere used when the substrate was identiﬁed by 35S
labeling, the ﬁrst to detect both 35S and 32P signals and the second the
32P signal.
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